Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ander Matheu

Showing results (91-100 of 124) with videos related to

Pageof 13
Sort By:
Expert Opinion on Therapeutic Targets|February 16, 2016
mTOR inhibition decreases SOX2-SOX9 mediated glioma stem cell activity and temozolomide resistanceLaura Garros-Regulez, Paula Aldaz, Olatz Arrizabalaga, et al.
Annals of Clinical and Translational Neurology|December 7, 2019
Leukocyte telomere length in patients with myotonic dystrophy type I: a pilot studyYoujin Wang, Ana Best, Roberto Fernández-Torrón, et al.
Cancer Research|February 17, 2021
Tumor-Derived Pericytes Driven by EGFR Mutations Govern the Vascular and Immune Microenvironment of GliomasBerta Segura-Collar, María Garranzo-Asensio, Beatriz Herranz, et al.
BMC Geriatrics|December 5, 2019
Description of frail older people profiles according to four screening tools applied in primary care settings: a cross sectional analysisItziar Vergara, Maider Mateo-Abad, María Carmen Saucedo-Figueredo, et al.
JCI Insight|August 30, 2022
Senescence plays a role in myotonic dystrophy type 1Mikel García-Puga, Ander Saenz-Antoñanzas, Gorka Gerenu, et al.
Cancers|February 25, 2022
SOX9 Triggers Different Epithelial to Mesenchymal Transition States to Promote Pancreatic Cancer ProgressionEstefania Carrasco-Garcia, Lidia Lopez, Veronica Moncho-Amor, et al.
Pharmaceuticals (Basel, Switzerland)|January 28, 2026
<i>Characterization</i> of a Novel Family of Contilisant + Belinostat Multitarget Small Molecules in GlioblastomaAizpea Artetxe-Zurutuza, Nerea Iturrioz-Rodriguez, Joseba Elizazu, et al.
Pharmaceutics|December 31, 2025
Generation and Characterization of Novel Contilisant+Tubastatin a Multitarget Small Molecules Against GlioblastomaIrati de Goñi, Aizpea Artetxe-Zurutuza, Joseba Elizazu, et al.
International Journal of Molecular Sciences|May 14, 2022
High SOX9 Maintains Glioma Stem Cell Activity through a Regulatory Loop Involving STAT3 and PMLPaula Aldaz, Natalia Martín-Martín, Ander Saenz-Antoñanzas, et al.
Cancer Research|February 8, 2022
Chaperone-Mediated Autophagy Controls Proteomic and Transcriptomic Pathways to Maintain Glioma Stem Cell ActivityJaione Auzmendi-Iriarte, Maddalen Otaegi-Ugartemendia, Estefania Carrasco-Garcia, et al.
Pageof 13

Showing results (91-100 of 124) with videos related to

Sort By:
Pageof 13
Expert Opinion on Therapeutic Targets|February 16, 2016
mTOR inhibition decreases SOX2-SOX9 mediated glioma stem cell activity and temozolomide resistanceLaura Garros-Regulez, Paula Aldaz, Olatz Arrizabalaga, et al.
Annals of Clinical and Translational Neurology|December 7, 2019
Leukocyte telomere length in patients with myotonic dystrophy type I: a pilot studyYoujin Wang, Ana Best, Roberto Fernández-Torrón, et al.
Cancer Research|February 17, 2021
Tumor-Derived Pericytes Driven by EGFR Mutations Govern the Vascular and Immune Microenvironment of GliomasBerta Segura-Collar, María Garranzo-Asensio, Beatriz Herranz, et al.
BMC Geriatrics|December 5, 2019
Description of frail older people profiles according to four screening tools applied in primary care settings: a cross sectional analysisItziar Vergara, Maider Mateo-Abad, María Carmen Saucedo-Figueredo, et al.
JCI Insight|August 30, 2022
Senescence plays a role in myotonic dystrophy type 1Mikel García-Puga, Ander Saenz-Antoñanzas, Gorka Gerenu, et al.
Cancers|February 25, 2022
SOX9 Triggers Different Epithelial to Mesenchymal Transition States to Promote Pancreatic Cancer ProgressionEstefania Carrasco-Garcia, Lidia Lopez, Veronica Moncho-Amor, et al.
Pharmaceuticals (Basel, Switzerland)|January 28, 2026
<i>Characterization</i> of a Novel Family of Contilisant + Belinostat Multitarget Small Molecules in GlioblastomaAizpea Artetxe-Zurutuza, Nerea Iturrioz-Rodriguez, Joseba Elizazu, et al.
Pharmaceutics|December 31, 2025
Generation and Characterization of Novel Contilisant+Tubastatin a Multitarget Small Molecules Against GlioblastomaIrati de Goñi, Aizpea Artetxe-Zurutuza, Joseba Elizazu, et al.
International Journal of Molecular Sciences|May 14, 2022
High SOX9 Maintains Glioma Stem Cell Activity through a Regulatory Loop Involving STAT3 and PMLPaula Aldaz, Natalia Martín-Martín, Ander Saenz-Antoñanzas, et al.
Cancer Research|February 8, 2022
Chaperone-Mediated Autophagy Controls Proteomic and Transcriptomic Pathways to Maintain Glioma Stem Cell ActivityJaione Auzmendi-Iriarte, Maddalen Otaegi-Ugartemendia, Estefania Carrasco-Garcia, et al.
Pageof 13